Radiation Oncology Journal

The Korean Society for Radiation Oncology (대한방사선종양학회)
권호 표지
DOI QR코드

DOI QR Code

The use of tissue fiducial markers in improving the accuracy of post-prostatectomy radiotherapy

  • Received : 2018.12.19
  • Accepted : 2019.02.12
  • Published : 2019.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: The aim of this retrospective study was to investigate the use of a radiopaque tissue fiducial marker (TFM) in the treatment of prostate cancer patients who undergo post-prostatectomy radiotherapy (PPRT). TFM safety, its role and benefit in quantifying the set-up uncertainties in patients undergoing PPRT image-guided radiotherapy were assessed. Materials and Methods: A total of 45 consecutive PPRT patients underwent transperineal implantation of TFM at the level of vesicourethral anastomosis in the retrovesical tissue prior to intensity-modulated radiotherapy. Prostate bed motion was calculated by measuring the position of the TFM relative to the pelvic bony anatomy on daily cone-beam computed tomography. The stability and visibility of the TFM were assessed in the initial 10 patients. Results: No postoperative complications were recorded. A total of 3,500 images were analysed. The calculated prostate bed motion for bony landmark matching relative to TFM were 2.25 mm in the left-right, 5.89 mm in the superior-inferior, and 6.59 mm in the anterior-posterior directions. A significant 36% reduction in the mean volume of rectum receiving 70 Gy (rV70) was achieved for a uniform planning target volume (PTV) margin of 7 mm compared with the Australian and New Zealand Faculty of Radiation Oncology Genito-Urinary Group recommended PTV margin of 10 mm. Conclusion: The use of TFM was safe and can potentially eliminate set-up errors associated with bony landmark matching, thereby allowing for tighter PTV margins and a consequent favourable reduction in dose delivered to the bladder and rectum, with potential improvements in toxicities.

Keywords

References

  1. Sidhom MA, Kneebone AB, Lehman M, et al. Postprostatectomy radiation therapy: consensus guidelines of the Australian and New Zealand Radiation Oncology Genito- Urinary Group. Radiother Oncol 2008;88:10-9. https://doi.org/10.1016/j.radonc.2008.05.006
  2. Bell LJ, Cox J, Eade T, Rinks M, Kneebone A. Prostate bed motion may cause geographic miss in post-prostatectomy image-guided intensity-modulated radiotherapy. J Med Imaging Radiat Oncol 2013;57:725-32. https://doi.org/10.1111/1754-9485.12089
  3. Huang K, Palma DA, Scott D, et al. Inter- and intrafraction uncertainty in prostate bed image-guided radiotherapy. Int J Radiat Oncol Biol Phys 2012;84:402-7. https://doi.org/10.1016/j.ijrobp.2011.12.035
  4. Song S, Yenice KM, Kopec M, Liauw SL. Image-guided radiotherapy using surgical clips as fiducial markers after prostatectomy: a report of total setup error, required PTV expansion, and dosimetric implications. Radiother Oncol 2012;103:270-4. https://doi.org/10.1016/j.radonc.2011.07.024
  5. Alander E, Visapaa H, Kouri M, Keyrilainen J, Saarilahti K, Tenhunen M. Gold seed fiducials in analysis of linear and rotational displacement of the prostate bed. Radiother Oncol 2014;110:256-60. https://doi.org/10.1016/j.radonc.2013.10.037
  6. Schiffner DC, Gottschalk AR, Lometti M, et al. Daily electronic portal imaging of implanted gold seed fiducials in patients undergoing radiotherapy after radical prostatectomy. Int J Radiat Oncol Biol Phys 2007;67:610-9. https://doi.org/10.1016/j.ijrobp.2006.09.042
  7. Fortin I, Carrier JF, Beauchemin MC, Beliveau-Nadeau D, Delouya G, Taussky D. Using fiducial markers in the prostate bed in postprostatectomy external beam radiation therapy improves accuracy over surgical clips. Strahlenther Onkol 2014;190:467-71. https://doi.org/10.1007/s00066-014-0631-3
  8. Bair RJ, Bair E, Viswanathan AN. A radiopaque polymer hydrogel used as afiducial marker in gynecologic-cancer patients receiving brachytherapy. Brachytherapy 2015;14:876-80. https://doi.org/10.1016/j.brachy.2015.08.008
  9. Chao M, Bolton D, Subramanian B, et al. The use of injectable TraceIT tissue marker to delineate bladder tumor volume for targeted partial bladder IMRT. Int J Urol 2016;23(Suppl 1):47.
  10. van Herk M. Errors and margins in radiotherapy. Semin Radiat Oncol 2004;14:52-64. https://doi.org/10.1053/j.semradonc.2003.10.003
  11. Huang EH, Pollack A, Levy L, et al. Late rectal toxicity: dosevolume effects of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2002;54:1314-21. https://doi.org/10.1016/S0360-3016(02)03742-2
  12. Michalski JM, Yan Y, Watkins-Bruner D, et al. Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trial. Int J Radiat Oncol Biol Phys 2013;87:932-8. https://doi.org/10.1016/j.ijrobp.2013.07.041
  13. Anscher MS, Clough R, Dodge R. Radiotherapy for a rising prostate-specific antigen after radical prostatectomy: the first 10 years. Int J Radiat Oncol Biol Phys 2000;48:369-75. https://doi.org/10.1016/S0360-3016(00)00645-3
  14. Cozzarini C, Montorsi F, Fiorino C, et al. Need for high radiation dose (>or=70 gy) in early postoperative irradiation after radical prostatectomy: a single-institution analysis of 334 high-risk, node-negative patients. Int J Radiat Oncol Biol Phys 2009;75:966-74. https://doi.org/10.1016/j.ijrobp.2008.12.059
  15. Valicenti RK, Gomella LG, Ismail M, Mulholland SG, Petersen RO, Corn BW. Effect of higher radiation dose on biochemical control after radical prostatectomy for PT3N0 prostate cancer. Int J Radiat Oncol Biol Phys 1998;42:501-6. https://doi.org/10.1016/S0360-3016(98)00270-3
  16. Connolly JA, Shinohara K, Presti JC Jr, Carroll PR. Local recurrence after radical prostatectomy: characteristics in size, location, and relationship to prostate-specific antigen and surgical margins. Urology 1996;47:225-31. https://doi.org/10.1016/S0090-4295(99)80421-X
  17. Leventis AK, Shariat SF, Slawin KM. Local recurrence after radical prostatectomy: correlation of US features with prostatic fossa biopsy findings. Radiology 2001;219:432-9. https://doi.org/10.1148/radiology.219.2.r01ma20432
  18. Scattoni V, Roscigno M, Raber M, et al. Multiple vesicourethral biopsies following radical prostatectomy: the predictive roles of TRUS, DRE, PSA and the pathological stage. Eur Urol 2003;44:407-14. https://doi.org/10.1016/S0302-2838(03)00320-8
  19. Liauw SL, Pitroda SP, Eggener SE, et al. Evaluation of the prostate bed for local recurrence after radical prostatectomy using endorectal magnetic resonance imaging. Int J Radiat Oncol Biol Phys 2013;85:378-84. https://doi.org/10.1016/j.ijrobp.2012.05.015
  20. Miralbell R, Vees H, Lozano J, et al. Endorectal MRI assessment of local relapse after surgery for prostate cancer: a model to define treatment field guidelines for adjuvant radiotherapy in patients at high risk for local failure. Int J Radiat Oncol Biol Phys 2007;67:356-61. https://doi.org/10.1016/j.ijrobp.2006.08.079
  21. Kitajima K, Murphy RC, Nathan MA, et al. Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET/CT with pelvic multiparametric MR imaging with endorectal coil. J Nucl Med 2014;55:223-32. https://doi.org/10.2967/jnumed.113.123018
  22. Broggi S, Cozzarini C, Fiorino C, et al. Modeling set-up error by daily MVCT for prostate adjuvant treatment delivered in 20 fractions: Implications for the assessment of the optimal correction strategies. Radiother Oncol 2009;93:246-52. https://doi.org/10.1016/j.radonc.2009.08.029

Cited by

  1. Salvage radiation therapy in prostate cancer: relationship between rectal dose and long-term, self-reported rectal bleeding vol.23, pp.2, 2019, https://doi.org/10.1007/s12094-020-02433-4
  2. The Feasibility of Haar Feature-Based Endoscopic Ultrasound Probe Tracking for Implanting Hydrogel Spacer in Radiation Therapy for Pancreatic Cancer vol.11, 2021, https://doi.org/10.3389/fonc.2021.759811